In a post in the Global Health Technologies Coalition’s “Breakthroughs” blog, the first in “a new blog series to highlight the impact of USAID’s commitment to global health research and development (R&D),” the coalition interviews Ted Prusik, senior vice president of Temptime, “a New Jersey-based company that has made a huge impact in global health with support from USAID.” According to the transcript, Prusik discusses his company’s partnership with USAID, highlights some of the health research successes achieved with USAID’s support, and discusses Temptime’s work with other global health partners, such as PATH, among other topics (Lufkin, 12/11).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.